Social characteristics of russian patients with psoriasis and arthropathic psoriasis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. According to the International Federation of Psoriasis Associations (IFPA), about 125 million people worldwide suffer from this disease. In Russia, at the end of 2022, based on the results of visits to medical organizations, more than 371.2 thousand patients with psoriasis were registered, and 94.2 thousand new cases of psoriasis were identified during this period. Features of the social characteristics of patients, including with psoriasis, not enough studied all over the world.

Objective. Evaluation of the influence of chronic skin disease (using the example of patients with psoriasis and arthropathic psoriasis) on the social activity of patients.

Methods. In order to study the influence of psoriasis and arthropathic psoriasis on the social activity of patients, an anonymous quantitative on-line survey of patients was conducted. The questionnaire included 36 questions. The object of the study was patients with a confirmed diagnosis of psoriasis and arthropathic psoriasis aged 18 to 75 years. Patients were included in the study regardless of the duration and severity of the disease. 512 respondents took part in the survey. After the “repair” the sample amounted to 486 people.

Results. It was revealed that the overwhelming majority of respondents do not have disabilities caused by psoriasis/arthropathic psoriasis (90.5%), did not receive therapy with genetically engineered biological drugs and did not encounter help (except for medical care) from government or public organizations (more than 90%). More than 85% of surveyed patients with psoriasis and arthropathic psoriasis do not receive medications for free. Moreover, almost half of the respondents spend up to 30% of their monthly income on medications necessary for treatment. In general, the presence of psoriasis/arthropathic psoriasis in patients does not interfere with their full work and study. At the same time, a significant portion of respondents had difficulties interacting with colleagues and friends due to the presence of these diseases, and 40% of respondents had to refuse job offers due to the presence of the disease. About half of the respondents experience various difficulties in their personal lives (the corresponding restrictions are manifested by both reluctance to enter into a long-term relationship and problems in intimate life, including among married respondents). Also, about half of the respondents experienced various difficulties in communication with their sexual partner, as well as in their sexual life. Moreover, more than 80% of patients with psoriasis/arthropathic psoriasis have the support of their family, which is an important factor in building self-confidence and reducing discomfort in creating new social connections.

Conclusion. The social characteristics of patients with psoriasis and arthropathic psoriasis, identified from the results of the study, can be used in preparing measures for the adaptation of patients, as well as programs for medical rehabilitation and prevention.

Full Text

Restricted Access

About the authors

A. A. Martynov

Russian Medical Academy of Continuous Professional Education

Email: pharmateca@yandex.ru
ORCID iD: 0000-0002-5756-2747
Russian Federation, Moscow

A. V. Vlasova

Russian Medical Academy of Continuous Professional Education

Author for correspondence.
Email: avvla@mail.ru
ORCID iD: 0000-0002-7677-1544

Can. Sci. (Med.)

Russian Federation, Moscow

O. S. Mishina

Interregional Charitable Public Organization “Skin and Allergic Diseases”

Email: pharmateca@yandex.ru
ORCID iD: 0000-0003-1172-4568
Russian Federation, Moscow

G. V. Lukyanova

St. Petersburg State University

Email: pharmateca@yandex.ru
ORCID iD: 0000-0003-1260-2124
Russian Federation, St. Petersburg

References

  1. URL: https://ncdalliance.org/international-federation-of-psoriasis-associations-ifpa.
  2. Котова Е.Г., Кобякова О.С., Кубанов А.А. и др. Ресурсы и деятельность медицинских организаций дерматовенерологического профиля. Заболеваемость инфекциями, передаваемыми половым путем, заразными кожными болезнями и болезнями кожи в 2022 году: статистические материалы. М., 2023. 209 с. [Kotova E.G., Kobyakova O.S., Kubanov A.A. and others. Resources and activities of medical organizations of dermatovenerological profile. Incidence of sexually transmitted infections, contagious skin diseases and skin diseases in 2022: statistical materials. M., 2023. 209 p. (In Russ.)]. doi: 10.21045/978-5-94116-1300-2023.
  3. Rapp S.R., Feldman Sr., Fleischer A.B., et al. Health related quality of life in psoriasis: A biopsychosocial model and measures. In: R. Rajagopalan, E.F. Sherertz, R. Anderson, ed. Care Management of Skin Diseases Life Quality and Economic Impact. Marcel Dekker, Inc. 1998. С. 125–45.
  4. Селин А.В. Жизненный путь личности в социальной ситуации хронического соматического заболевания. Дисс. канд. психол. наук. Курск, 2009. [Selin A.V. The life path of an individual in the social situation of chronic somatic disease. Diss. Cand. of Psychol. Sciences. Kursk, 2009. (In Russ.)].
  5. Anstey A., McAteer H., Kamath N., Percival F. Extending psychosocial assessment of patients with psoriasis in the UK, using a self-rateds, web-based survey. Clin Exp Dermatol. 2012;37(7);735–40.
  6. Bardazzi F., Odorici G., Ferrara F., et al. Sex and the PASI: patients affected by a mild form of psoriasis are more predisposed to have a more severe form of erectile dysfunction. J Eur Acad Dermatol Venereol. 2016;30(8):1342–8.
  7. Kouris А., Platsidaki E., Kouskoukis C., Christodoulou C. Psychological parameters of psoriasis. Psychiatriki. 2017;28:54–9.
  8. Gupta M.A., Schork N.J., Gupta A.K., et al. Suicidal ideation in psoriasis. Int J Dermatol. 1993;32:188–90.
  9. Vardy D., Besser A., Amir M., et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol. 2002;147:736–42.
  10. Esposito M., Saraceno R., Giunta A., et al. An Italian study on psoriasis and depression. Dermatol. 2006;212:123–27.
  11. Шевченко Н.А., Ивашкина М.Г., Чернов Д.Н. и др. Особенности психосексуальной функции у женщин, страдающих псориазом. Международный научно-исследовательский журнал. 2020;12(102). [Shevchenko N.A., Ivashkina M.G., Chernov D.N. and others. Features of psychosexual function in women suffering from psoriasis. Int Sci Res J. 2020;12(102). (In Russ.)]. doi: 10.23670/IRJ.2020.102.12.065.
  12. Ружинских Г.А. Клинико-психологические особенности внутренней картины болезни у больных псориазом и псориатическим артритом. Неврологический вестник. 2015;XLVII(4):34–9. [Ruzhinskikh G.A. Clinical and psychological features of the internal picture of the disease in patients with psoriasis and psoriatic arthritis. Nevrologicheskii vestnik. 2015;XLVII(4):34–9. (In Russ.)].
  13. Kouris А., Platsidaki Е., Kouskoukis С., Christodoulou С. Psychological parameters of psoriasis. Psychiatriki. 2017;28:54–9.
  14. Wahl A.K., Gjengedal E., Hanestad B.R. The bodily suffering of living with severe psoriasis: in -depth interviews with 22 hospitalized patients with psoriasis patients. Qual. Health Res. 2002;12:250–61.
  15. McKenna S.P., Cook S.A., Whalley D., et al. Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003;149:323–31.
  16. Weiss S.C., Kimball A.B., Liewehr D.J., et al. Quantifying the harmful effects of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;4:512–18.

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Рис. 1. Уровень образования и сфера занятости пациентов, %

Download (159KB)
3. Рис. 2. Число случаев, когда приходилось отказываться от построения отношений из-за Пс/ПсАпсориаза артропатического, %

Download (73KB)
4. Рис. 3. Пс/ПсА мешает моей половой жизни

Download (73KB)
5. Рис. 4. Моя семья поддерживает меня, когда я испытываю трудности в связи с Пс/ПсА, %

Download (70KB)
6. Рис. 5. Ежемесячные расходы на лекарственные препараты/мази/медицинские изделия и другие вещи, необходимые для терапии Пс/ПсА, %

Download (52KB)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies